Navigation Links
Arena Pharma, Geron, Incyte, and Spectrum Pharma Under AAAResearchReports.com Microscope
Date:7/29/2013

LONDON, July 29, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

On Friday, July 26, 2013, shares of biotech companies ended mostly lower even as the broader market posted gains. The major movers in the industry included Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), Geron Corporation (NASDAQ: GERN), Incyte Corporation (NASDAQ: INCY), and Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI). AAAResearchReports.com has released full comprehensive research on ARNA, GERN, INCY, and SPPI. These free technical analyses can be downloaded by signing up at:

http://www.aaaresearchreports.com/register/  

Shares of Arena Pharmaceuticals, Inc. fell sharply on Friday, finishing at $6.86, down 2.14% from its previous trading session's closing price. The company's shares oscillated between $6.83 and $7.01. A total of 3.01 million shares were traded, which is below the daily average volume of 5.84 million. Arena's shares have fallen by 10.91% in the last one month as compared to a loss of 0.03% in the S&P 500. A free technical analysis on ARNA available by signing up at:

http://www.AAAResearchReports.com/ARNA072913.pdf

Geron Corporation's stock fell sharply on Friday, extending its losses for the week. The company's shares oscillated between $1.38 and $1.44 before ending the day 4.17% lower at $1.38. A total of 260,089 shares were traded, which is below the daily average volume of 994,053. The company's shares fell by 6.76% last week. Nonetheless, the stock has advanced 21.05% in the last three
'/>"/>

SOURCE AAA Research Reports
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. SynCardia Total Artificial Heart Bridges Former Semi-Pro Arena Football Player to Heart Transplant
2. Todays Research on Incyte and Arena Pharma: Biotech Stocks Up on Drug Approvals
3. New Competitive Arena Emerges for Pharmaceutical Companies in Healthcares Changing Payment Landscape, Finds PwC Health Research Institute Study
4. Todays Technical View: AstraZeneca, GlaxoSmithKline, Keryx Biopharma, and Raptor Pharma
5. Technical Briefing: Amgen, PDL BioPharma, Questcor Pharma, and BioCryst Pharma
6. MannKind, Ariad Pharma, Ziopharm Oncology, Galena Biopharma, and Novavax Under StockCalls Microscope
7. Amarin, Pharmacyclics, Anthera Pharma, Star Scientific, and Impax Laboratories Under StockCalls Microscope
8. Air Products to Feature Medical and Industrial Grade Gas Solutions for Pharma, Biotech, and Life Science Applications at Mid-Atlantic Bio Conference
9. ARMGO Pharma, Inc. announces data which supports its Rycal program as a novel approach for the treatment of stress-induced cognitive disorders
10. Enox Biopharma, Inc. Grants TTA LTD License To Wound Care Applications
11. Enox Biopharma, Inc. Will Present at IN360 Investment in Innovation Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 21, 2014  Decision Resources Group finds that ... and Mexico currently ... newly approved agents, the anticipated label extension of ... launch of emerging biologics will substantially increase the ... emerging IL-5 inhibitors will introduce a new dynamic to ...
(Date:8/21/2014)... , Aug. 21, 2014 ... Immune Pharmaceuticals Inc., a biotechnology company, on its ... Immune previously traded on OTCQX®, the best marketplace ... OTC Markets Group. Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO ... on the successful execution of its growth strategy ...
(Date:8/21/2014)... Aug. 21, 2014  Four-dimensional (4-D) printing develops ... on external stimuli such as changes in temperature. ... disruptive effect in multiple industries.  In the near ... by printing objects ranging from human organs to ... Logo - http://photos.prnewswire.com/prnh/20140820/138289 ...
(Date:8/21/2014)... Ontotext S4 , The Self Service ... Now the same enterprise hardened text mining, Linked ... data is available to start-ups and mid-size businesses at ... that do not have resources to evaluate and prototype ... since there is no need for on premise hardware ...
Breaking Biology Technology:Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 2Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 3OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing 2Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 2Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 3Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 4Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 3Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 4
... BEDFORD, Mass., Sept. 2 VisEn Medical Inc., a leader ... today the commercial launch of its new Annexin-Vivo 750 imaging ... . The new Annexin-Vivo 750 agent is based on ... It is expected to significantly expand research areas and enhance drug development ...
... , , SAN DIEGO, Sept. 2 ... OPTR ) lead developmental product candidates will be ... and Chemotherapy (ICAAC) to be held at The Moscone Center in San ... http://www.newscom.com/cgi-bin/prnh/20090413/LA97352LOGO ) , , , ...
... , SILVER SPRING, Md., Sept. 1 United Therapeutics ... of Directors has approved and declared a stock split. The ... dividend, in which one share of United Therapeutics common stock will ... (or held in treasury) at the close of business on the ...
Cached Biology Technology:VisEn Launches New Annexin-Vivo 750 Fluorescence Molecular Imaging Agent 2VisEn Launches New Annexin-Vivo 750 Fluorescence Molecular Imaging Agent 3Optimer Pharmaceuticals Announces Presentations of Additional Phase 3 Fidaxomicin and Prulifloxacin Data at Upcoming ICAAC Annual Meeting 2Optimer Pharmaceuticals Announces Presentations of Additional Phase 3 Fidaxomicin and Prulifloxacin Data at Upcoming ICAAC Annual Meeting 3United Therapeutics Corporation Announces Stock Split To Be Effected as a Stock Dividend 2
(Date:8/21/2014)... Israel Deaconess Medical Center (BIDMC ) are among the ... Minds 2014," a comprehensive list compiled by ... science metrics and research performance analysis. , ... performing and publishing work that their peers recognized as ... a Thomson Reuters statement. Researchers were identified based on ...
(Date:8/21/2014)... of the water window? It consists of radiations in ... absorbed by the water in biological tissues. New theoretical ... radiations within the water window. These could be the ... image of the biological samples or to be used ... the physical mechanism needed to efficiently generate the harmonic ...
(Date:8/21/2014)... tube connectors, designed by an international standards process, will ... According to an invited review published in the OnlineFirst ... NCP ), the official journal of the American Society ... will greatly reduce the occurrence of misconnection that can ... connectors, which are used to join medical devices, components, ...
Breaking Biology News(10 mins):BIDMC researchers named among 'the most influential scientific minds' 2BIDMC researchers named among 'the most influential scientific minds' 3Water window imaging opportunity 2New feeding tube connectors will improve patient safety 2
... Saturday 02 April 2011: Promising new viral hepatitis data ... entry inhibitors --a new mechanism of action for drugs ... new hepatitis B and hepatitis D treatments for many ... replication (e.g. nucleotide/side analogues), and can lead to the ...
... greenhouse industry is big business in the United ... agricultural sales. Most of the ornamental plants grown ... greenhouse operations. These operations are classified as "intensive ... expensive resources (labor, water, and fertilizers) to produce ...
... on England,s unused agricultural land could produce enough biomass ... industry or the environment, according to research led by ... The study, funded by the UK Energy Research Centre ... which looks at the potential of planting short rotation ...
Cached Biology News:Entry inhibitors show promise as drugs with new MOA for treatment of HBV and HDV infection 2Green industry knowledge center introduced 2Green industry knowledge center introduced 3Short rotation energy crops could help meet UK's renewable energy targets 2
... The Fujifilm Life Science FLA-7000 excels at ... CBB-stained gel documentation. It features four easy-to-access ... and a filter for Imaging Plates) for ... a customizable choice of four kinds of ...
... has been optimized for the analysis of ... software to quickly and accurately locate and ... an ELISA plate or each section of ... been customized to incorporate standard ELISA analysis ...
For microscopy...
... General description: Humidity wells in the ... maintain chamber humidity and probe hydration around ... seal eliminates the risk of waterbath contamination. ... constant temperature waterbaths or hybridisation ovens. Linkage: ...
Biology Products: